Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
94.00
+1.52 (1.64%)
At close: Apr 28, 2026, 4:00 PM EDT
94.50
+0.50 (0.53%)
Pre-market: Apr 29, 2026, 4:36 AM EDT
Mirum Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5,732 | 4,083 | 1,985 | 1,376 | 719 | 486 | |
| Market Cap Growth | 198.94% | 105.67% | 44.25% | 91.51% | 47.79% | -4.80% | |
| Enterprise Value | 5,668 | 4,026 | 2,018 | 1,378 | 535 | 299 | |
| Last Close Price | 94.00 | 78.99 | 41.35 | 29.52 | 19.50 | 15.95 | |
| PS Ratio | 11.00 | 7.83 | 5.89 | 7.38 | 9.32 | 25.41 | |
| PB Ratio | 15.50 | 12.97 | 8.80 | 5.53 | 5.06 | 4.04 | |
| P/TBV Ratio | 106.60 | 75.93 | - | - | 8.65 | 4.79 | |
| P/FCF Ratio | 104.46 | 74.40 | 212.71 | - | - | - | |
| P/OCF Ratio | 102.67 | 73.13 | 192.25 | - | - | - | |
| EV/Sales Ratio | 10.87 | 7.72 | 5.99 | 7.39 | 6.95 | 15.62 | |
| EV/EBITDA Ratio | 2688.82 | 1909.74 | - | - | - | - | |
| EV/FCF Ratio | 103.29 | 73.36 | 216.27 | - | - | - | |
| Debt / Equity Ratio | 1.01 | 1.01 | 1.41 | 1.24 | 0.02 | 0.02 | |
| Debt / EBITDA Ratio | 70.86 | 70.86 | - | - | - | - | |
| Debt / FCF Ratio | 5.82 | 5.82 | 34.05 | - | - | - | |
| Net Debt / Equity Ratio | -0.20 | -0.20 | 0.17 | 0.09 | -1.05 | -1.28 | |
| Net Debt / EBITDA Ratio | -30.30 | -30.30 | -0.58 | -0.22 | 1.17 | 0.89 | |
| Net Debt / FCF Ratio | -1.16 | -1.16 | 4.01 | -0.31 | 1.24 | 1.16 | |
| Asset Turnover | 0.69 | 0.69 | 0.51 | 0.37 | 0.24 | 0.07 | |
| Inventory Turnover | 4.24 | 4.24 | 3.65 | 3.38 | 3.50 | - | |
| Quick Ratio | 2.46 | 2.46 | 2.83 | 4.07 | 2.72 | 3.76 | |
| Current Ratio | 2.67 | 2.67 | 3.10 | 4.45 | 2.94 | 3.91 | |
| Return on Equity (ROE) | -8.65% | -8.65% | -37.08% | -83.65% | -103.46% | -57.47% | |
| Return on Assets (ROA) | -1.83% | -1.83% | -8.31% | -13.65% | -25.33% | -40.48% | |
| Return on Capital Employed (ROCE) | -3.50% | -3.50% | -16.10% | -19.50% | -45.50% | -68.80% | |
| Earnings Yield | -0.41% | -0.57% | -4.43% | -11.88% | -18.88% | -17.27% | |
| FCF Yield | 0.96% | 1.34% | 0.47% | -5.16% | -16.76% | -27.31% | |
| Buyback Yield / Dilution | -5.63% | -5.63% | -16.23% | -20.31% | -12.07% | -20.08% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.